Abstract
A method or use of administering an anti-B7H3 antibody-drug conjugate in combination with other therapeutic agents for treating cancer. The other therapeutic agents are selected from anti-PD-1 antibodies or antigen-binding fragments or/and chemotherapeutic drugs thereof. Also provided is a use of the combination in a pharmaceutical composition and a pharmaceutical kit for treating cancer.
Full Text
What is claimed is:
A method or use of administering an anti-B7H3 antibody-drug conjugate in combination with other therapeutic agents for treating cancer. The other therapeutic agents are selected from anti-PD-1 antibodies or antigen-binding fragments or/and chemotherapeutic drugs thereof. Also provided is a use of the combination in a pharmaceutical composition and a pharmaceutical kit for treating cancer.
Timeline
Filed
05/13/2026Published
09/03/2026Granted
Not AvailableIPC Codes(6)
A61K 47/68:the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 39/00:Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53)